But it wasn't the meningitis, which she overcame with help of powerful antibiotics, that was the problem. It was what came after: the clostridium difficile, or C. diff. The antibiotics used to treat ...
SEATTLE, April 3, 2025 /PRNewswire/ -- In a landmark achievement for its pioneering spirulina-based drug development platform, Lumen announced today top-line results from the sentinel cohort of its ...
In a total of 26 ibezapolstat-treated patients in Phases 2a and 2b, the Clinical Cure rate is 96% Meets protocol primary objective of assessing the primary efficacy endpoint of the Clinical Cure rate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results